IL197868A - Isoform of human alpha-enolase and methods and kits for the diagnosis of pancreatic ductal adenocarcinoma - Google Patents

Isoform of human alpha-enolase and methods and kits for the diagnosis of pancreatic ductal adenocarcinoma

Info

Publication number
IL197868A
IL197868A IL197868A IL19786809A IL197868A IL 197868 A IL197868 A IL 197868A IL 197868 A IL197868 A IL 197868A IL 19786809 A IL19786809 A IL 19786809A IL 197868 A IL197868 A IL 197868A
Authority
IL
Israel
Prior art keywords
pda
antibodies
enoa
enolase
proteins
Prior art date
Application number
IL197868A
Other languages
English (en)
Other versions
IL197868A0 (en
Original Assignee
Ribovax Biotechnologies S A
Bioline Diagnostici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribovax Biotechnologies S A, Bioline Diagnostici Srl filed Critical Ribovax Biotechnologies S A
Publication of IL197868A0 publication Critical patent/IL197868A0/en
Publication of IL197868A publication Critical patent/IL197868A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G01N33/57525—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/01—Hydro-lyases (4.2.1)
    • C12Y402/01011—Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
    • G01N33/575—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
IL197868A 2006-09-29 2009-03-26 Isoform of human alpha-enolase and methods and kits for the diagnosis of pancreatic ductal adenocarcinoma IL197868A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06121552 2006-09-29
EP06126726 2006-12-20
PCT/EP2007/060305 WO2008037792A1 (en) 2006-09-29 2007-09-28 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma

Publications (2)

Publication Number Publication Date
IL197868A0 IL197868A0 (en) 2011-08-01
IL197868A true IL197868A (en) 2013-03-24

Family

ID=38895810

Family Applications (2)

Application Number Title Priority Date Filing Date
IL197868A IL197868A (en) 2006-09-29 2009-03-26 Isoform of human alpha-enolase and methods and kits for the diagnosis of pancreatic ductal adenocarcinoma
IL218442A IL218442A0 (en) 2006-09-29 2012-03-01 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL218442A IL218442A0 (en) 2006-09-29 2012-03-01 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma

Country Status (18)

Country Link
US (1) US8071721B2 (enExample)
EP (1) EP2069395B1 (enExample)
JP (1) JP2010505104A (enExample)
KR (1) KR20090094227A (enExample)
CN (1) CN101578295B (enExample)
AT (1) ATE542831T1 (enExample)
AU (1) AU2007301966B2 (enExample)
BR (1) BRPI0717282A2 (enExample)
CA (1) CA2664841A1 (enExample)
DK (1) DK2069395T3 (enExample)
EA (1) EA016731B1 (enExample)
ES (1) ES2381304T3 (enExample)
IL (2) IL197868A (enExample)
NO (1) NO20091662L (enExample)
NZ (1) NZ576409A (enExample)
PL (1) PL2069395T3 (enExample)
PT (1) PT2069395E (enExample)
WO (1) WO2008037792A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009137832A2 (en) * 2008-05-09 2009-11-12 Duke University Autoantibodies in the detection and treatment of cancer
IT1398782B1 (it) * 2009-09-11 2013-03-18 Novelli Peptide monofosforilato isolato derivato dall'alfa-enolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi.
ITTO20120523A1 (it) * 2012-06-15 2013-12-16 Natimab Therapeutics S R L Procedimento e kit per la diagnosi in vitro dell'adenocarcinoma duttale pancreatico o per determinare la predisposizione all'adenocarcinoma duttale pancreatico
EP3083697B1 (en) * 2013-12-20 2019-04-17 Development Center for Biotechnology Alpha-enolase specific antibodies and methods of uses in cancer therapy
WO2015106296A1 (en) 2014-01-13 2015-07-16 Berg Llc Enolse 1 (eno1) compositions and uses thereof
CN115786317A (zh) * 2022-12-12 2023-03-14 江苏三联生物工程股份有限公司 重组神经元特异性烯醇化酶及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753446A (en) * 1993-04-15 1998-05-19 National Jewish Center For Immunology & Respiratory Medicine Mitogen ERK kinase kinase (MEKK) assay

Also Published As

Publication number Publication date
AU2007301966B2 (en) 2013-02-21
ES2381304T3 (es) 2012-05-25
AU2007301966A1 (en) 2008-04-03
KR20090094227A (ko) 2009-09-04
WO2008037792A1 (en) 2008-04-03
IL218442A0 (en) 2012-04-30
IL197868A0 (en) 2011-08-01
EA200970332A1 (ru) 2009-10-30
CA2664841A1 (en) 2008-04-03
ATE542831T1 (de) 2012-02-15
PT2069395E (pt) 2012-04-27
US8071721B2 (en) 2011-12-06
NZ576409A (en) 2012-02-24
JP2010505104A (ja) 2010-02-18
US20100028907A1 (en) 2010-02-04
BRPI0717282A2 (pt) 2013-10-15
EP2069395A1 (en) 2009-06-17
CN101578295B (zh) 2013-02-27
NO20091662L (no) 2009-06-29
PL2069395T3 (pl) 2012-06-29
DK2069395T3 (da) 2012-05-14
EA016731B1 (ru) 2012-07-30
EP2069395B1 (en) 2012-01-25
CN101578295A (zh) 2009-11-11

Similar Documents

Publication Publication Date Title
US8071721B2 (en) Antigens and antibodies associated to pancreatic ductal adenocarcinoma
Chu et al. Mapping Post-translational Modifications of the Histone Variant MacroH2A1 Using Tandem Mass Spectrometry* S
EP3047277B1 (en) Autoantibody biomarkers of ovarian cancer
He et al. Phosphatidylethanolamine binding protein 4 (PEBP4) is a secreted protein and has multiple functions
Frączyk et al. Properties of phosphorylated thymidylate synthase
Sheng et al. SENP1-mediated deSUMOylation of YBX1 promotes colorectal cancer development through the SENP1-YBX1-AKT signaling axis
EP3042203B1 (en) Biomarkers for cholangiocellular carcinoma (ccc)
Zhang et al. Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA
US20180156819A1 (en) Method for monitoring cancer and/or inflammatory reaction based on relb phosphorylation
WO2010071788A1 (en) Pancreatic cancer markers and uses thereof
Kannaiah et al. MinD-RNase E interplay controls localization of polar mRNAs in E. coli
Thakar et al. SUMOylation of the hepatoma‐derived growth factor negatively influences its binding to chromatin
Fleron et al. Novel post-digest isotope coded protein labeling method for phospho-and glycoproteome analysis
KR101296743B1 (ko) 심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법
DK2447719T3 (en) proteins
US10401371B2 (en) Method of measuring cholesterol levels by using immunogenic method
CN119213025A (zh) 与α-1,6-核心-岩藻糖基化的甲胎蛋白特异性结合的高亲和力抗体
Saar-Kovrov et al. Protein carbamylation in atherosclerotic plaques correlates with uremia and disease progression, localizing predominantly to foam cells
Cho et al. Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells
EP3346271A1 (en) Methods and kits for detecting cancer
Maksym et al. Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection
Semaan Proteomics of putative protein biomarkers in human breast cancer tissues
Castillo Mass Spectrometry-Based Approaches for Targeted Quantitative Proteomics in Biomarker Development
WO2011140478A2 (en) Compositions and methods for detecting acetylated sumo proteins

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees